dihexa parkinson's | 1401708-83-5 | BGC70883 Dihexa | 1401708-83-5

The compound appears to maintain NO homeostasis under conditions of both excess and deficiency upregulating eNOS-derived NO in ischemic models while attenuating iNOS-driven overproduction in inflammatory contexts (Sikiric et al., 2014, Current Pharmaceutical Design 2014

To have a dose of 0.25 mg pull the syringe to 250 mcg (g) 10 units Medical Disclaimer This calculator is for informational purposes only and does not constitute medical advice

[Google Scholar] 328.Herbst RS et al

You have a right to know exactly what is being injected into your body

In the US, be cautious with any peptide sold without clinician oversight